| DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) - BioAssay Summary DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) ..more |
_ | |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target
BioActive Compounds: 29 Description: DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) Comment Compounds with activity <= 50uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation. Publication: Journal: NULL Year: NULL Volume: NULL Issue: NULL First Page: NULL Last Page: NULL Categorized Comment ChEMBL Assay Type: Binding ChEMBL Assay Data Source: DrugMatrix in vitro pharmacology assays ChEMBL Assay Test Type: In vitro ChEMBL Assay Cell Type: HEK293 ChEMBL Assay Subcellular Fraction: membranes ChEMBL Target ID: 137 ChEMBL target type: Target is a single protein chain Result Definitions
* Activity Concentration. Data Table (Concise) Classification
PageFrom: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||